Which of the following statements is incorrect regarding Samter's triad?

Correct Answer: B. It is only triggered by aspirin.

Samter's triad (also called aspirin-exacerbated respiratory disease or AERD) is fundamentally a disorder of COX-1 inhibition, not aspirin-specific toxicity. The discriminating fact is that ANY NSAID capable of blocking COX-1 can trigger the syndrome—aspirin is merely the most common culprit. The pathophysiology involves shunting of arachidonic acid metabolism away from the blocked COX-1 pathway toward the 5-lipoxygenase pathway, causing massive overproduction of cysteinyl leukotrienes (LTC4, LTD4, LTE4). These leukotrienes trigger bronchoconstriction, nasal congestion, and angioedema. NSAIDs like ibuprofen, naproxen, and indomethacin—all COX-1 inhibitors—can provoke identical reactions in susceptible patients. Selective COX-2 inhibitors (e.g., celecoxib) are generally safe because they spare COX-1. The statement "only triggered by aspirin" is factually incorrect and represents a common misconception in clinical practice. Indian guidelines and Harrison's textbook emphasize that patient counseling must include avoidance of all COX-1-blocking NSAIDs, not just aspirin.

Why the other options are wrong

A. It is characterized by asthma, nasal polyps, and aspirin sensitivity. — This is the correct clinical definition of Samter's triad. The triad consists of these three cardinal features: chronic asthma (often severe and difficult to control), chronic rhinosinusitis with nasal polyps, and reproducible reactions to NSAIDs. This statement is accurate and is NOT the incorrect statement the question asks for. It serves as a distractor for students who confuse the definition with the trigger mechanism. C. Other NSAIDs with COX-1 blocking ability can also trigger symptoms. — This is factually correct and is a critical clinical pearl. The syndrome is triggered by COX-1 inhibition, not aspirin per se. Ibuprofen, naproxen, indomethacin, and other non-selective NSAIDs all carry risk. This statement accurately reflects the pathophysiology and is NOT the incorrect statement. Students who understand the mechanism will correctly identify this as true. D. It involves overproduction of leukotrienes. — This is pathophysiologically accurate. COX-1 blockade shunts arachidonic acid toward 5-lipoxygenase, causing overproduction of cysteinyl leukotrienes (LTC4, LTD4, LTE4). These leukotrienes mediate the bronchoconstriction, nasal symptoms, and angioedema. Leukotriene receptor antagonists (montelukast) and 5-lipoxygenase inhibitors are therapeutic options. This statement is correct and NOT the answer.

High-Yield Facts

Mnemonics

AERD = COX-1 Block → Leukotrienes ↑ Aspirin-Exacerbated Respiratory Disease is triggered by COX-1 blockade (not aspirin alone), causing shunting to 5-LO → LT overproduction. Remember: it's the pathway shift, not the drug name. NSAIDs to AVOID in Samter's: Non-selective (COX-1 blockers) Ibuprofen, Naproxen, Indomethacin = INI = all trigger AERD. Celecoxib (COX-2 selective) = Clear to use. Mnemonic: INI = Incriminated, C = Clean.

NBE Trap

NBE exploits the common misconception that Samter's triad is an aspirin-specific allergy. By pairing "only triggered by aspirin" with the correct definition (option A), students who memorize the triad name without understanding the COX-1 mechanism will incorrectly choose option A as the "incorrect" statement.

Clinical Pearl

In Indian clinical practice, many patients with Samter's triad are misdiagnosed as having "aspirin allergy" and are only counseled to avoid aspirin. This leads to dangerous use of other NSAIDs (e.g., ibuprofen for fever or pain) that trigger severe bronchospasm. Proper patient education must emphasize avoidance of ALL non-selective NSAIDs and safe alternatives (acetaminophen, selective COX-2 inhibitors, or leukotriene antagonists).

_Reference: Harrison's Principles of Internal Medicine, Ch. 297 (Asthma); KD Tripathi Pharmacology, Ch. 27 (NSAIDs and Respiratory Pharmacology)_